| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |